Boris Labar

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

R Zittoun, Franco Mandelli, Roel Willemze et al. · New England Journal of Medicine · 1995 · 854 citations · Full text

Medicine, Hematology, Oncology +14

Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

Michael Lübbert, Stefan Suciu, Liliana Baila et al. · Journal of Clinical Oncology · 2011 · 551 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma

Heinz Ludwig, Roman Hájek, Elena Tóthová et al. · Blood · 2008 · 206 citations · Full text

Medicine, Hematology, Oncology +13

Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10

Franco Mandelli, Marco Vignetti, Stefan Suciu et al. · Journal of Clinical Oncology · 2009 · 188 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial

R. Willemze, Stefan Suciu, Giovanna Meloni et al. · Journal of Clinical Oncology · 2013 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17